تحلیل اختیاری محصول
با اجازه شما، از تحلیلهای محدود و حریمخصوصیمحور استفاده میکنیم تا مسیرهای پژوهشی مؤثر را بشناسیم. از ردیاب تبلیغاتی یا بازپخش نشست استفاده نمیکنیم. این انتخاب را میتوانید در تنظیمات تغییر دهید. بخوانید سیاست حفظ حریم خصوصی.
Erie Indemnity Company's published Sell conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $12.5B | |
|---|---|---|
| Revenue (ttm) | 4.1B | |
| Net income (ttm) | 577M | |
| EPS (ttm) | $11.0 | |
| Shares out | 52.3M | |
| P/E (trailing) | 22.2x | |
| P/E (forward) | 26.7x | |
| Dividend | $5.85 (2.39%) | |
| Volume | 127,947 | |
| Beta | 0.33 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $2.63B | $2.84B | $3.27B | $3.80B | $4.07B | +11.5% |
| Gross profit | $2.70B | $376.2M | $520.3M | $676.5M | $640.8M | -30.2% |
| Operating income | $318.1M | $376.2M | $520.3M | $676.5M | $717.2M | +22.5% |
| Net income | $297.9M | $298.6M | $446.1M | $600.3M | $559.3M | +17.1% |
| EPS (diluted) | $5.61 | $6.08 | $8.69 | $11.49 | $12.24 | +21.5% |
| EBITDA | $-286.1M | $428.4M | $600.2M | $766.3M | $787.4M | — |
| R&D | $0 | $0 | $0 | — | — | +10.2% |
| SG&A | $58.3M | $668.3M | $737.1M | $806.3M | $74.1M | +6.2% |
Recent company headlines from major financial publishers.
In the base scenario, management fee revenue grows steadily in line with regional premium expansion while operating margins remain stable. Reinvestment moderates gradually, aligning intrinsic worth with Fair value $151.31 against the share price at analysis $239.05.
In the bull scenario, policyholder expansion into contiguous states accelerates while modern software deployments streamline administrative operations. Capital spending normalizes toward depreciation, releasing free cash flow and supporting Potential value $226.92.
| Ke ↓ / g → | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 5.0% | $188 | $206 | $230 | $267 | $327 |
| 6.0% | $158 | $168 | $180 | $197 | $220 |
| 7.0% | $138 | $144 | $151 | $161 | $172 |
| 8.0% | $123 | $127 | $132 | $138 | $145 |
| 9.0% | $112 | $115 | $118 | $122 | $127 |
Upcoming earnings date and setup when available.
رتبهای که نسخهٔ پژوهشی منتشرشدهٔ هر ماه داشت. رتبه قیمت در تاریخ تحلیل را با ارزش منصفانه مقایسه میکند و سابقهای از درستی یا نادرستی ارزیابی نیست.
| سال | دی | بهمن | اسفند | فروردین | اردیبهشت | خرداد | تیر | مرداد | شهریور | مهر | آبان | آذر |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
